Sanofi forges $1.2bn alliance with vaccines firm Novavax May 10, 2024 AutoBot News 0 Sanofi has licensed joint commercial rights to Novavax’s COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up to $1.2 billion.